Pfizer has entered a collaboration with IBM Watson to utilize its drug discovery technology to help accelerate research in immuno-oncology. Pfizer is among the first organizations to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool, which taps in to Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies, and patient selection strate...